Zamzow, K. et al., New Wearable Continuous Blood Glucose Monitor (BGM) and Artificial Pancreas (AP), Diabetes, 39:5A(20) (May 1990).
Zhang, Y et al. “Application of cell culture toxicity tests to the development of implantable biosensors,” Biosensors & Bioelectronics, 6:653-661(1991).
Zhang, Y et al., “Elimination of the Acetaminophen Interference in an Implantable Glucose Sensor,” Anal. Chem. 66: 1 183-1 188 (1994). Batchelor et al., “Amperometric Assay for the Ketone body 3-Hydroxybutyrate,” Analytica Chimica Acta, 221:289-294 (1989). Choleau et al., “Calibration of a subcutaneous amperometric glucose sensor Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current,” Biosensors and Bioelectronics, 17:641-646 (2002).
Kerner et al., “The function of a hydrogen peroxide-detecting electroenzyrnatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma,” Biosensors & Bioelectronics, 8:473-482 (1993).
Linke et al., “Prevention of the Decrease in Sensitivity of an Amperometric Glucose Sensor in Undiluted Human Serum,” Clinical Chemistry, 45( 2):283-285 (1999).
Pickup et al., “Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man,” Acta. Diabetol., 30:143-148 (1993).
Pravda, M. et al., “Evaluation of amperometric glucose biosensors based on co-immobilisation of glucose oxidase with an osmium redox polymer in electrochemically generated polyphenol films,” Analytica Chimica Acta, 304:127-138 (1995).
TheraSense, Inc., v. Becton, Dickinson and C0., 560 F. Supp. 2d 835iDist. Court, ND California (Apr. 3, 2008).
Thomé-Duret et al., “Modification of the Sensitivity of Glucose Sensor Implanted into Subcutaneous Tissue,” Diabetes & Metabolism (Paris), 22:174-178 (1996).
Ward et al., “A new amperometric glucose n1icrosensor: in vitro and short-term in vivo evaluation,” Biosensors & Bioelectronics, 17: 181189 (2002).